---

FULL-SERVICE CDMO >>
FOR A GLOBAL MARKET

---

Dr. Lutz Henkel
Managing Director,
CordenPharma Plankstadt

Dr. Lutz Henkel joined CordenPharma as Managing Director, CordenPharma Plankstadt in October 2020. Bringing more than 30 years of experience in the pharmaceutical industry, Lutz joins us from Bipso / Bracco, where he was the Director of Quality & Compliance. Prior to that, he held various key positions in Operations and Quality Management within Big Pharma (including Pfizer), as well as Generic and CDMO organizations. Lutz holds a PhD in Pharmacy from the Martin-Luther-Universität Halle-Wittenberg in Germany.

Dr. Lee Newton
Chief Operating Officer,
CordenPharma

Dr. Lee Newton joins CordenPharma from Lonza, where he most recently held the role of Senior Vice President & Business Unit Head for Lonza’s Small Molecule API business. Lee has over 20 years of experience within the Pharmaceutical Industry. After beginning his career in primary manufacturing with GlaxoWellcome, Lee moved into the CDMO sector in 2002 with Avecia, and has since worked in various operational & commercial roles with increasing responsibility including as Operations Director for Carbogen Amcis. He holds a PhD in Organic Chemistry from the University of Heriot-Watt (UK). Lee is Scottish national currently residing in Switzerland.

William Cashin
Chief Quality & Compliance Officer,
CordenPharma

William Cashin joined CordenPharma as Chief Quality & Compliance Officer in May 2020. Will joins us from Lonza, where he served as Global Head Quality, Mammalian and Microbial. In this role, he was directly responsible for all aspects of quality for biopharmaceutical global manufacturing operations within Europe, North America, Singapore and China. Prior to that, Will worked extensively in the pharmaceutical industry, including roles of increasing responsibility at Alexion, GSK and Pfizer. He holds a Bachelor’s degree in Applied Chemistry from the Waterford Institute of Technology in Ireland and a Master’s degree in Business Administration from the Open University, (UK). William is an Irish national, currently based in Switzerland.

Dr. Walter Kittl
Interim Managing Director,
CordenPharma Plankstadt

Dr. Walter Kittl is the Interim Managing Director, CordenPharma Plankstadt, starting March 19, 2020. With over 35 years of experience in the pharmaceutical, CMO and fine chemical industries, Walter brings a holistic understanding of pharmaceutical manufacturing operations resulting from a multi-faceted career beginning as a Project Manager in R&D and manufacturing at DSM Fine Chemicals. Walter then held various senior management positions with increasing levels of responsibility at Roche, where he became Site Manager of the Basel Chemical Manufacturing site, and Siegfried AG, where he was President & General Manager of Siegfried USA before becoming the Head of Global Technical Operations. Walter is an Austrian citizen and holds a Ph.D. in Chemistry from the Leopold-Franzens University of Innsbruck, Austria.

Jason Bertola
Director, Global Highly Potent & Oncology Platform,
CordenPharma International

Jason Bertola joined CordenPharma in 2016 as Director, Global Highly Potent & Oncology Platform, CordenPharma International. Jason began his career in pharmaceutical process development first with SAPEC (now Cerbios) and then Hoffmann-La Roche before transitioning into business development and sales. He brings over 27 years of diverse leadership experience in the pharmaceutical industry with extensive expertise in contract development and manufacturing, strategy development and business transactions. Prior to joining CordenPharma, Jason was Vice President of Business Development & Strategy for Dishman. Jason holds a B.S. in Chemistry and an MBA from Fairleigh Dickinson University.

Dr. Stephen Houldsworth
VP, Global Head of Platform Management & Marketing,
CordenPharma International

Dr. Stephen Houldsworth is currently the VP, Global Head of Platform Management & Marketing. With over twenty years in the CDMO industry, Stephen joined CordenPharma in 2017 as Director, Global Small Molecules & Antibiotics Platforms. Prior to joining CordenPharma Stephen held various senior positions in R&D, Manufacturing, Operations, Business Development and Sales in Dalton Pharma Services and most recently Apotex Pharmachem. Stephen has a Ph.D. in organic chemistry from the University of Nottingham (UK) where he conducted research in the group of Prof. G. Pattenden, followed by a postdoctoral stay in the group of V. Snieckus at the University of Waterloo (CA).

Dr. Michael Quirmbach
Chief Executive Officer & President,
CordenPharma

Dr. Michael Quirmbach joined CordenPharma in October 2014, holding positions first as Vice President, Marketing & Sales and Chief Business Officer before becoming Chief Executive Officer & President as of August 1, 2019. Prior to joining CordenPharma, Michael held positions with increasing responsibility at Albany Molecular Research (AMRI), Solvias AG, Speedel, Dr. Reddy’s, and Siegfried AG, where he garnered extensive experience in business development, marketing, and sales in the CDMO arena. Michael studied chemistry at the Technical University of Clausthal (DE) and the University of Salford (UK) before completing his PhD at the the Max Planck Research Group “Asymmetric Catalysis” at the Institute for Organic Catalysis Research in Rostock (DE). Following a postdoctoral fellowship at both the University of Colorado, Boulder (USA) and the University of Pennsylvania (USA), Michael completed his MBA from La Salle University in Philadelphia (USA) in 2005.

Dr. Juerg Burger
Managing Director,
CordenPharma Switzerland

Dr. Juerg Burger joined CordenPharma in 2013 as the Managing Director, CordenPharma Switzerland (CH). Prior to joining CordenPharma, Dr. Burger garnered extensive operations management experience over 27 years in various roles at Lonza AG (CH and Hopkinton, US) including Head of Manufacturing Business Sector Exclusive Synthesis, Head of Manufacturing Operations for Pharmaceuticals (small molecules) and later Microbial Fermentations, and most recently Head Business Unit of Global Microbial Operations, VP of Supply Chain and VP of Head Site Services. Dr. Burger earned a PhD and Master Degree in Chemical Engineering from the Swiss Federal Institute of Technology in Zurich (CH).

Yves Michon
Managing Director,
CordenPharma Chenôve

Yves Michon joined CordenPharma in January 2011 as Managing Director, CordenPharma Chenôve (FR) and ad interim for CordenPharma Brussels (BE). Yves brings 30 years of experience in the manufacturing and business of Fine Chemicals and APIs with expertise in Production, Continuous Improvement, Project Management and General Management of CMOs. He holds a Master of Science Degree in Process Control & Engineering from ECAM Graduate School of Engineering in Lyon, France.

Dr. Matthieu Giraud
Director, Global Peptides, Lipids & Carbohydrates Platform,
CordenPharma International

Dr. Matthieu Giraud joined CordenPharma in 2017 as Director, Global Peptides, Lipids & Carbohydrates Platform, CordenPharma International. Prior to joining CordenPharma Matthieu held various senior positions in the CMO business, with >10 years of experience in increasingly senior roles, culminating as the Director, Head of R&D Peptides and Oligonucleotides at Lonza (CH), then Head of API production at BASF Pharma (CH), API Site Manager at BASF Pharma (FR), and finally Key Account Manager for Siegfried (CH). Matthieu has a Ph.D. in peptide chemistry from the University of Montpellier (FR), where he conducted research in the group of Prof. J. Martinez, jointly with Osaka University in the group of Prof. Shimonishi.

Laura Coppi joined CordenPharma in October 2013 as Managing Director, CordenPharma Bergamo (IT) after more than 20 years of experience in various management positions in the pharmaceutical chemical industry. Laura began her career in Process R&D at Zambon Group in 1988. In 1992 her professional pathway shifted toward business and management as Technical Marketing Manager, EAME Generic Sales Manager and Worldwide Contract Manufacturing Manager at Zambon. In 1998 Laura came to the USA to work for Davos Chemical Corporation as Technical Marketing and Key Account Manager. In 1998, Laura went back to Europe and worked for 9 years at the Spanish private group Esteve as R&D and IP Director (Esteve Quimica) and General Manager (Pensa Pharma in Milan). In 2007, Laura joined Wyeth Pharmaceuticals’ New Product and Process Development division as Sr. Director of API Technical Operations, followed by positions as Managing Director of Archimica Srl and Marketing and Sales Director of F.I.S. As an Organic Chemist of the University of Florence, Specialist in Synthetic Organic Chemistry of the University of Milan and author of several publications and patents, Laura complemented her scientific education with a diploma in Marketing from Bocconi University in Milan and a PDG from Iese in Barcelona.

Frank Haehner joined CordenPharma in 2016 as Managing Director, CordenPharma Plankstadt, (DE). He has more than 25 years of experience in the pharmaceutical industry in various executive roles. Prior to joining CordenPharma Frank worked at Novartis, where he served as Head of Technology & Investment Portfolio Management, Head of Engineering Biologics, Technical Development and Manufacturing, as well as Project Director of BioInject, a new biopharmaceutical manufacturing facility. Prior to that, Frank held senior roles at B.Braun Melsungen AG as Head of Technical Development, Vice President Special Projects (US) and Project Director for a new green field Pharma Factory. During his relationship with io-consultants, Heidelberg, Frank was Senior Business Unit Manager, Pharma and a member of the supervisory board of io-consultants China. Frank graduated with a degree in Process Engineering and Chemical Engineering from the Technical University of Kaiserslautern, Germany, where we went on to receive his PhD in Process Engineering.

Heiko Serwe joined CordenPharma as Chief Financial Officer in May 2018 from the industrial holding company ADCURAM Group, where he worked as Commercial Director and CFO for a number of portfolio companies, and took over an important role during several M&A transactions. Prior to that Heiko held various positions of increasing responsibility at the pharmaceutical primary packaging manufacturer Gerresheimer, culminating as CFO of the Tubular Glass business unit. Heiko is a German citizen with a degree in Mechanical Engineering from the University of Hannover, DE and a degree in Economics from the University of Hagen, DE.

Starting May 2018, Eng. Alessandro Zucconi joined CordenPharma as Managing Director, CordenPharma Latina (IT). Alessandro has more than 30 years of experience in various management positions of increasing responsibility within different industrials sectors, mainly the automotive business, gained in both domestic (Italian) and International markets, and 20 years of experience as a CEO. After graduating with a degree in Mechanical Engineering from the University of Pisa (IT), Alessandro complemented his scientific education with a Business Master degree in Enterprise Strategy from Bocconi University in Milano (IT), and a Master in Business Coaching Certification ICF from IN Coach Academy in Milano (IT).

Fabrizio Fiordigiglio joined CordenPharma in November 2017 as Managing Director, CordenPharma Caponago (IT) after more than 30 years of experience in different management positions in the chemical and pharmaceutical industry. After graduating as a Chemical Engineer from the Milan Politecnico University, Fabrizio began his career as Chemical Project Manager in Lamberti Group in 1985. In 1989 he joined Akzo Nobel Chemicals with increasing responsibility until taking the role as Site Manager for one of the Italian production sites. In 1999 he joined the CDMO API manufacturing company UQUIFA as General Manager and later on became the Managing Director for the Italian manufacturing subsidiary. In 2012 he joined the CDMO Tubilux Pharma, located near Rome, as General Manager active in the aseptic filling ophthalmic business.

Patrice Locht joined CordenPharma in 2016 as the Managing Director, CordenPharma Brussels (BE). Patrice started his career with several operational roles of increasing responsibility in diversified industries including catalytic systems (Johnson Matthey), detergents and power cables (Nexans) before moving to the genomics and diagnostic GMP grade components business as a Production Manager. Patrice holds a Master degree in Applied Sciences and an International Executive Master of Business Administration degree from the University of Louvain (Belgium).

Brian McCudden joined CordenPharma as Managing Director, CordenPharma Boulder & CordenPharma Colorado (Boulder, CO, USA) in June 2014. Brian is an API executive with extensive experience developing and implementing strategy and building high performing teams. He has broad experience at establishing and improving operations in development, manufacturing, supply chain, sourcing and procurement in API and finished Drug Product. Brian graduated from the University of Delaware with a degree in Chemical Engineering and has an MBA in Finance from Loyola College. Prior to accepting his current position with CordenPharma Colorado, he served as the Vice President, API Strategy at Hospira. Brian also worked for Roche Colorado Corporation as Director of Manufacturing from 1991 – 2002.

Fabio Stevanon became Director, Global Injectables Platform, CordenPharma International in January 2018. Fabio joined CordenPharma Caponago in July 2009, after previously being with AstraZeneca, where he garnered extensive experience as Logistic & IT Director over 15 years in the area of Injectable product operation. Furthermore, he was involved in supporting AstraZeneca’s supply-sourcing management team for a number of core Injectable products contracted to CMOs. Additional areas of experience included lean strategic program and business process engineering. Fabio received an industrial engineering degree from Politecnico Milano and started his industrial career in the automotive industry, where he worked in supply chain, operations and towards the implementation of lean manufacturing techniques.